---
title: 'Scientist I, High-Throughput Biology at Eikon Therapeutics'
canonical: 'https://feeny.ai/job/scientist-i-high-throughput-biology-eikon-therapeutics-millbrae-m74ftqevc49h'
type: 'job'
last_seen: '2026-11-08'
---

# Scientist I, High-Throughput Biology at Eikon Therapeutics

- **Company:** Eikon Therapeutics
- **Location:** Millbrae, CA
- **Posted:** 2026-11-03
- **Last confirmed live:** 2026-11-08
- **Apply:** https://job-boards.greenhouse.io/eikontherapeutics/jobs/5277276007

## Job description

Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the intersection of chemistry, engineering, computation, and biology to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular-resolution measurements of protein movement in living cells, thereby unlocking otherwise intractable classes of proteins as drug targets.

Position

As a member of the High-Throughput Biology Team, you will play a key role in pioneering drug discovery screening assays using Eikon’s proprietary live-cell, single-molecule high-throughput super-resolution microscopy platform. You will work at the intersection of biology, automation engineering, and computational science to design, execute and deliver scalable, reproducible, decision-enabling biological data that drives progress across drug discovery portfolios.

## About You

You are a highly motivated, rigorous, and interdisciplinary scientist who enjoys developing, optimizing, and validating live-cell imaging-based assays at scale to push the frontier of drug discovery. You are creative, data-driven, and skilled at problem solving in a fast-paced, dynamic, and matrixed environment. You are conscientious, detail-oriented, and organized, and are committed to delivering high-quality and actionable data in a timely manner. You are an effective communicator and teammate who is eager to learn and collaborate with people from diverse scientific backgrounds.

## What You’ll Do

- Design, execute, and analyze robust and reproducible experiments to optimize, validate, and scale up live-cell imaging-based assays for high-throughput screening using Eikon’s proprietary super-resolution microscopy platform.
- Collaborate with computational biologists and software engineers to apply state-of-the-art computational and statistical methods including machine-learning to analyze large datasets.
- Summarize and deliver timely, high-quality and actionable data to drive project team decisions across drug discovery portfolios.
- Exercise good scientific judgment and provide data-driven recommendations to project teams.
- Maintain organized and comprehensive electronic records of experiments, results, and protocols in adherence to company standards and regulatory requirements.
- Work closely with the High-Throughput Biology Operations Team to transfer optimized processes into productionized operations workflows with well-documented standard operating procedures.
- Collaborate and communicate across a diverse team of biologists, chemists, and engineers.
- Contribute to the growth and training of junior scientists.

## Qualifications

- Ph.D. or Master’s plus 10 years of relevant experience or Bachelor’s degree plus 12 years of relevant experience in Biology, Bioengineering, Biotechnology, or related field.
- Proficiency in mammalian cell culture with sterile technique.
- Proficiency in laboratory techniques and equipment relevant to molecular and cellular biological research.
- Demonstrated experience in systematic optimization and validation of biological assays.
- Strong analytical and troubleshooting skills with novel assay technologies.
- Working experience in quantitative fluorescence microscopy and/or super-resolution microscopy.
- Working experience with relevant quantitative and/or statistical analysis using common software tools (e.g., Microsoft Suite, GraphPad Prism, etc.).
- Working experience with one or more high-level programming languages (e.g., Python, MATLAB or R) to perform large dataset analysis and visualization.
- Excellent communication skills, with the ability to convey scientific concepts effectively.
- Collaborative mindset with the capacity to work effectively within multidisciplinary teams.
- Proactive and adaptable to evolving research priorities and challenges.
- Working experience in protein dynamics using single-molecule microscopy is preferred.
- Working experience with high-throughput instrumentation and automation systems is preferred.

At Eikon, employee compensation also includes bonus and equity compensation, in addition to several generous benefit programs, including:​

- 401k plan with company matching​
- Medical (premiums covered by Eikon at 95%), dental and vision insurance (premiums covered by Eikon at 100%)​
- Mental health and wellness benefits​
- Weeklong summer and winter holiday shutdowns​
- Generous paid time off and holiday policies​
- Life/AD&D Insurance (premiums covered by Eikon at 100%) and optional supplemental employee-paid life/AD&D policies ​
- Enhanced parental leave benefit​
- Daily subsidized lunch program when on-site​

The expected salary range for this role is $123,000 to $149,100 depending on skills, competency, and the market demand for your expertise. Eikon is proud to be an equal opportunity employer and will consider all qualified applicants for employment.

We are currently not accepting any new third-party agencies or firms at this time. Please do not forward unsolicited agency resumes to our website, employees or Human Resources. Eikon Therapeutics will not pay fees to any third-party agency or firm associated with unsolicited resumes.

## About Eikon Therapeutics

## Company Overview
- **One-liner**: Eikon Therapeutics is a late-stage clinical biopharmaceutical company that integrates single-molecule imaging, machine learning, and engineering to discover and develop novel therapies for oncology, immunology, and neuroscience.
- **Entity Type**: Public (NASDAQ: EIKN) – originally privately held, went public via a post-IPO equity round in 2026.
- **Headquarters**: Millbrae, California, United States
- **Founded**: 2019
- **Founders**: Not publicly named in the search results; the company was seeded by The Column Group.

## Core Business
- **Primary industry**: Biotechnology research and drug development (therapeutics)
- **Target customers**: Patients with unmet medical needs; the company partners with clinical research organizations, healthcare providers, and regulators.
- **Mission or purpose statement**: “Better insights will lead to better medicines” – the company aims to introduce new therapies that improve and extend life by deeply understanding human disease biology.

## Products & Services
- **EIK10 (TLR7/8 agonist)**: Phase 2 clinical program for solid tumors, leveraging immune response modulation.
- **VCP inhibitor (undisclosed target)**: Phase 1 program in oncology.
- **AR-v7 degrader**: Preclinical/early clinical program targeting androgen receptor splice variant in cancer.
- **PARP1 inhibitor**: Early-stage oncology program; also a CNS-penetrant PARP1 candidate for neuroscience.
- **AR degrader**: Preclinical androgen receptor degrader.
- **Discovery-stage programs**: Multiple undisclosed targets in oncology, immunology, and neuroscience, supported by the company’s single-molecule imaging platform.

## Market Standing
- **Valuation/Market Cap**: Not disclosed in search results; total funding of ~$1.5B as of mid-2026.
- **Key Metrics**:
  - Annual Revenue: $5.6M (reflective of early-stage, pre-commercial biotech).
  - Total Funding: $1.5B (seed, Series A $148M in 2021, Series B $518M in 2022, Series C $106M in 2023, and post-IPO equity of $381.2M in 2026).
- **Notable Investors/Partners**: The Column Group (lead seed/Series A), 18 investors in Series B, and multiple institutional partners across rounds; board includes industry veterans (e.g., Roger Perlmutter, former Merck CEO).
- **Growth Signals**:
  - Headcount grew ~2.7% YoY to 314 employees (2025–2026).
  - Active job postings increased 270% year-over-year (as of mid-2026).
  - Expanding pipeline into immunology and neuroscience beyond oncology.
  - Recent $351M financing event (reported by multiple outlets) to fund late-stage trials.

## Competitive Advantages
- **Proprietary single-molecule imaging platform** that enables real-time observation of protein dynamics at the single-molecule level, providing insights into disease mechanisms that traditional methods miss.
- **Machine learning integration** to analyze massive imaging datasets, accelerating target identification and drug design.
- **Deep bench of scientific talent**: Executives include Roger Perlmutter (CEO, ex-Merck), Roy Baynes (CMO, ex-Merck), and a team drawing from Genentech, Bristol Myers Squibb, Pfizer, and top academic institutions.
- **Cross-disciplinary approach** merging biology, engineering, and computation under one roof, reducing the “translation gap” between discovery and clinic.

## Strategic Focus
- **Advancing late-stage oncology pipeline**: Lead program (TLR7/8 agonist) in Phase 2, with plans to move into pivotal trials.
- **Expanding into new therapeutic areas**: Significant preclinical investment in immunology and neuroscience, with CNS-penetrant PARP1 and AR programs.
- **Continued platform development**: Scaling imaging and machine learning capabilities to enable faster, more precise drug discovery across multiple indications.
- **Building commercial infrastructure**: Post-IPO financing supports preparation for potential product launches and expanded clinical operations.

## Why Work Here
- **Culture**: Values-driven environment prioritizing execution, collaboration, innovation, transparency, respect, and caring for patients and colleagues.
- **Engineering & science fusion**: Opportunity to work at the intersection of advanced imaging, machine learning, and drug development – unique in biotech.
- **Growth trajectory**: Young company with strong funding, public listing, and rapidly expanding pipeline; employees can have significant impact.
- **Compensation**: Competitive base salaries (e.g., Software Engineer ~$140k, Senior Software Engineer ~$167k) plus equity incentives.
- **Work model**: Likely office-based at the Millbrae HQ or satellite labs in Hayward, CA; clinical roles may require travel; no explicit remote/hybrid policy in search results.
- **Perks**: Not detailed, but typical biotech benefits (health, 401k, PTO) are assumed; the company emphasizes a “transparent and inclusive culture” per its values.
- **Employee sentiment**: Overall rating 3.0/5 on LinkedIn (66 reviews); work-life balance 3.2, compensation 3.4, culture 3.0, career opportunities 2.9 – indicating room for improvement in career development.

## Sources
1. [eikontx.com](https://www.eikontx.com/)
2. [eikontx.com/about-us](https://www.eikontx.com/about-us/)
3. [eikontx.com/join-us](https://www.eikontx.com/join-us/)
4. [eikontx.com/pipeline](https://www.eikontx.com/pipeline/)
5. [linkedin.com/company/eikon-therapeutics-inc](https://www.linkedin.com/company/eikon-therapeutics-inc)

## Other roles at Eikon Therapeutics

- [Manager, Study Start Up](https://feeny.ai/job/manager-study-start-up-eikon-therapeutics-jersey-city-sjbsvdttnvc6) — Jersey City, NJ
- [Director, Site Engagement & Monitoring Excellence (CONTRACT)](https://feeny.ai/job/director-site-engagement-monitoring-excellence-contract-eikon-therapeutics-mq2a3tcremrq) — Jersey City, NJ / Millbrae, CA
- [Clinical Trial Associate, APAC (CONTRACT)](https://feeny.ai/job/clinical-trial-associate-apac-contract-eikon-therapeutics-jersey-city-q6jkqzeyd2k2) — Jersey City, NJ / Millbrae, CA
- [Lab Operations Supervisor](https://feeny.ai/job/lab-operations-supervisor-eikon-therapeutics-millbrae-x3vbjdmv2xtb) — Millbrae, CA
- [Senior Scientist I, Cheminformatics](https://feeny.ai/job/senior-scientist-i-cheminformatics-eikon-therapeutics-millbrae-2m0m09mnsw8c) — Millbrae, CA
- [Senior Manager, Pharmacovigilance](https://feeny.ai/job/senior-manager-pharmacovigilance-eikon-therapeutics-jersey-city-85a1kxt3zerr) — Jersey City, NJ
- [Clinical Quality Operations Manager](https://feeny.ai/job/clinical-quality-operations-manager-eikon-therapeutics-millbrae-0mczwgq31knh) — Millbrae, CA / Jersey City, NJ
- [Senior Director, Translational Medicine](https://feeny.ai/job/senior-director-translational-medicine-eikon-therapeutics-jersey-city-1697yzqsxsjb) — Jersey City, NJ / Millbrae, CA
- [Associate Director, Clinical Data Management](https://feeny.ai/job/associate-director-clinical-data-management-eikon-therapeutics-jersey-city-6rkwk4ya8pa0) — Jersey City, NJ / Millbrae, CA
- [Scientist, Computational Biology](https://feeny.ai/job/scientist-computational-biology-eikon-therapeutics-millbrae-feqcsff97ncf) — Millbrae, CA